Guideline: Screening for prostate cancer (Republic of Cyprus) - Revision history

Lucas: Update categories.

2025-12-14T12:03:25Z

Update categories.

← Older revision		Revision as of 12:03, 14 December 2025
Line 27:		Line 27:
	<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>		<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
	<span style="display:none">hasCancerType::C00-C97: All cancer types</span>		<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
			<span style="display:none">Prostatic</span>
			<span style="display:none">Testicular</span>
			<span style="display:none">Penile</span>

Lucas: Update categories.

2025-12-10T19:07:37Z

Update categories.

@@ Line 23: / Line 23: @@
 <span style="display:none">availableVariable::screening</span>
 <span style="display:none">availableVariable::check-up examinations</span>
 <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
 <span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
 <span style="display:none">hasCancerType::C00-C97: All cancer types</span>

Lucas: Update categories.

2025-12-06T12:12:37Z

Update categories.

← Older revision		Revision as of 12:12, 6 December 2025
Line 27:		Line 27:
	<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>		<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
	<span style="display:none">hasCancerType::C00-C97: All cancer types</span>		<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
			<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
			<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
			<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
			<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
			<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
			<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
			<span style="display:none">hasCancerType::C50: Breast cancer</span>
			<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
			<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
			<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
			<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
			<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
			<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
			<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
			<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
			<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
			<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
			<span style="display:none">hasCancerType::unknown</span>

Lucas: Update categories.

2025-12-06T11:22:38Z

Update categories.

← Older revision		Revision as of 11:22, 6 December 2025
Line 25:		Line 25:
	<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>		<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
	<span style="display:none">isPracticeGuideline</span>		<span style="display:none">isPracticeGuideline</span>
			<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
			<span style="display:none">hasCancerType::C00-C97: All cancer types</span>

Lucas: Update categories.

2025-12-04T16:43:32Z

Update categories.

← Older revision		Revision as of 16:43, 4 December 2025
Line 24:		Line 24:
	<span style="display:none">availableVariable::check-up examinations</span>		<span style="display:none">availableVariable::check-up examinations</span>
	<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>		<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
			<span style="display:none">isPracticeGuideline</span>

Larysse at 15:31, 4 December 2025

2025-12-04T15:31:29Z

← Older revision		Revision as of 15:31, 4 December 2025
Line 1:		Line 1:
	<span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span>		<span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span>
			<span style="display:none">republicofcypruscountry</span>
	Go back to [[Republic of Cyprus]] page		Go back to [[Republic of Cyprus]] page

Lucas: Update categories.

2025-12-02T13:34:51Z

Update categories.

← Older revision		Revision as of 13:34, 2 December 2025
Line 1:		Line 1:
	{{forproviders~~}} {{~~forpolicymakers}}		<span style="display:none">forproviders</span> <span style="display:none">forpolicymakers</span>
	Go back to [[Republic of Cyprus]] page		Go back to [[Republic of Cyprus]] page

Line 12:		Line 12:
	'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to access].		'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to access].

	{{Prostate}}		<span style="display:none">Prostate</span>
	{{Testicles}}		<span style="display:none">Testicles</span>
	{{Penis}}		<span style="display:none">Penis</span>
			<span style="display:none">dataOwner::Ministry of Health</span>
			<span style="display:none">dataOwner::Health Insurance Organization</span>
			<span style="display:none">availableVariable::diagnosis</span>
			<span style="display:none">availableVariable::medical procedures</span>
			<span style="display:none">availableVariable::age</span>
			<span style="display:none">availableVariable::screening</span>
			<span style="display:none">availableVariable::check-up examinations</span>
			<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>

Lara at 17:53, 12 September 2024

2024-09-12T17:53:41Z

← Older revision		Revision as of 17:53, 12 September 2024
Line 11:		Line 11:

	'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to access].		'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to access].

			{{Prostate}}
			{{Testicles}}
			{{Penis}}

Francine at 19:35, 23 July 2024

2024-07-23T19:35:36Z

← Older revision		Revision as of 19:35, 23 July 2024
Line 8:		Line 8:
	'''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. [[availableVariable::diagnosis]], [[availableVariable::medical procedures]], [[availableVariable::age]], [[availableVariable::screening]], [[availableVariable::check-up examinations]].		'''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. [[availableVariable::diagnosis]], [[availableVariable::medical procedures]], [[availableVariable::age]], [[availableVariable::screening]], [[availableVariable::check-up examinations]].

	'''Cancer Areas of Interest:''' [[hasCancerType::C60-C63: Male genitalia cancer]]. [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/~~3B7C3521A6E9A1BBC2257CF30028391C/$file/Προσυμπτωματικός%20έλεγχος%20για%20καρκίνο%20του%20προστάτη.pdf~~ Click here to learn more].		'''Cancer Areas of Interest:''' [[hasCancerType::C60-C63: Male genitalia cancer]]. [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to learn more].

	'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/~~3B7C3521A6E9A1BBC2257CF30028391C/$file/Προσυμπτωματικός%20έλεγχος%20για%20καρκίνο%20του%20προστάτη.pdf~~ Click here to access].		'''Access to information:''' [https://www.moh.gov.cy/moh/moh.nsf/bf38a2d2e174417cc225782600313992/3b7c3521a6e9a1bbc2257cf30028391c?OpenDocument Click here to access].

Francine at 19:34, 23 July 2024

2024-07-23T19:34:22Z

← Older revision		Revision as of 19:34, 23 July 2024
Line 4:		Line 4:
	'''Primary purpose:''' To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer.		'''Primary purpose:''' To outline the risk assessment and recommended procedures for PSA testing to detect prostate cancer.

	'''Sponsor, manager or home institution:''' [[dataOwner::Ministry of Health]] and [[dataOwner:Health Insurance Organization]].		'''Sponsor, manager or home institution:''' [[dataOwner::Ministry of Health]] and [[dataOwner::Health Insurance Organization]].

	'''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. [[availableVariable::diagnosis]], [[availableVariable::medical procedures]], [[availableVariable::age]], [[availableVariable::screening]], [[availableVariable::check-up examinations]].		'''Type of information:''' This guideline provides risk percentages for prostate cancer based on PSA levels, along with screening recommendations considering age, race, family history, and other factors affecting PSA results. It also includes guidance on when to pursue further diagnostic procedures and highlights the importance of individualized patient-physician discussions. [[availableVariable::diagnosis]], [[availableVariable::medical procedures]], [[availableVariable::age]], [[availableVariable::screening]], [[availableVariable::check-up examinations]].